Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Track and Trace Standards Coming Shortly, FDA Says

Executive Summary

Standards were required in FDAAA; industry asked for them in part to avoid conflicts with California pedigree law that will be implemented in 2015.


Related Content

Draft Guidances For 2013 Will Grapple With Biosimilars, Track and Trace, Compounding
PDUFA’s ‘Huge’ GMP Change Will Tie Adulteration To Quality System
“Comprehensive” Drug Shortage Mitigation Bill Under Development In House
FDA Wants Authority To Enforce Track-And-Trace System For Drugs
Rx Shortages Defy Easy Solutions, FDA Notes As It Offers Congress Some Ideas
Not Another FDAAA – Observers Expect Fewer FDA Reforms In PDUFA V
FDA Cloak And Dagger: GMP "Intelligence" Sought As Part Of Globalization Plan
FDA Refining "Track And Trace" Standards For Rx Drugs
FDA Delays Implementation Of Radiofrequency Identification Standards
FDA Takes First Step Towards "Track And Trace" As Final Guidance Lengthens Identifiers For Drug Packaging





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts